Incidence of Postoperative Residual Neuromuscular Blockade in the Era of Sugammadex

Seoul National University Hospital52 enrolled

Overview

This study is a prospective observational study. A total 52 patients will be included in this study. We will observe the incidence of postoperative residual neuromuscular blockade in patients receiving sugammadex.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Postoperative Residual Curarization

Interventions

SugammadexDRUG

At the end of surgery, neuromucular blockade will be reversed with 2mg/kg or 4mg/kg sugammadex depending on the depth of neuromuscular blockade.

Eligibility

Sex: ALLMin age: 19 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients undergoing elective surgery under general anesthesia. * American Society of Anesthesiologists grade 1, 2, or 3. * Aged \>18 years Exclusion Criteria: * Refusal to participate in the study * Body Mass Index \< 18.5 kg/m2 or \> 35 kg/m2 * History of neuromuscular disease. * History of allergy to neuromuscular blockade * Scheduled to transfer to the intensive care unit

Locations (1)

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea

RECRUITING

Outcomes

Primary Outcomes

Postoperative residual neuromuscular blockade

TOF ratio \< 0.9

Time frame: On the arrival of PACU

Central Contacts

Chang-Hoon Koo

CONTACT

+821085098841 vollock9@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.